Effect of a Mixture of Allium Extracts on LDL Cholesterol Levels Volunteers With Elevated LDL Cholesterol Levels
Study Details
Study Description
Brief Summary
To evaluate the efficacy of daily consumption of a combination of concentrated extracts of garlic (Allium sativum L.) and onion (Allium cepa L.) on LDL cholesterol levels in healthy volunteers. Parameters related to metabolic syndrome, cardiovascular health and the immune system will also be analyzed.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
It is a controlled, randomized, double-blind, parallel-group nutritional intervention study.
64 healthy volunteers lwith elevated LDL cholesterol levels but who do not require pharmacological treatment will be randomly distributed into 2 equal groups: control group and intervention group.
For 8 weeks the volunteers will take the product immediately after lunch. During that time they will maintain their lifestyle and nutritional habits.
Blood samples will be taken at 0, 2, 4 and 8 weeks. Anthropometric parameters and health-related data were also measured.
Parameters related to lipid metabolism, metabolic syndrome and the immune system will be analized.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Placebo Comparator: Control Microcrystalline cellulose (9892- Capsules®) up to 400 mg. |
Dietary Supplement: Garlic and onion concentrate
Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).
Other Names:
Dietary Supplement: Control
Microcrystalline cellulose
Other Names:
|
Experimental: Intervention Garlic concentrated extract. Onion concentrated extract. Microcrystalline cellulose (9892- Capsules®) up to 400 mg. |
Dietary Supplement: Garlic and onion concentrate
Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).
Other Names:
Dietary Supplement: Control
Microcrystalline cellulose
Other Names:
|
Outcome Measures
Primary Outcome Measures
- LDL [8 weeks.]
Serum LDL cholesterol
Secondary Outcome Measures
- Cholesterol [8 weeks]
Serum total cholesterol
- HDL [8 weeks]
Serum HDL cholesterol
- Triglycerides [8 weeks]
Serum triglycerides
- Glucose [8 weeks]
Serum glucose
- CRP [8 weeks]
C-reactive protein in serum
- Oxidized LDL cholesterol [8 weeks]
Oxidized LDL cholesterol in plasma
- MDA [8 weeks]
Malondialdehyde in plasma
- TAC [8 weeks]
Plasma total antioxidant capacity
- Selenium [8 weeks]
Serun selenium
- Selenoprotein P [8 weeks]
Selenoprotein P in plasma
- VCAM-1 [8 weeks]
Endothelial adhesion molecules VCAM-1 in plasma
- ICAM-1 [8 weeks]
Endothelial adhesion molecules ICAM-1 in plasma
- IL1 beta in plasma [8 weeks]
Interleukin-1 beta in plasma
- IL 6 [8 weeks]
Interleukin-6 in plasma
- IL 10 [8 weeks]
Interleukin-10 in plasma
- BMI [8 weeks]
Body mass index (height/weight ratio)
- Abdominal perimeter [8 weeks]
Abdominal perimeter in centimeters
- Blood pressure [8 weeks]
Systolic pressure and diastolic pressure)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
LDL-cholesterol levels between 100 and 190 mg/dL.
-
Freely agree to participate in the study and sign the informed consent document.
Exclusion Criteria:
-
Be pregnant.
-
Have planned to change lifestyle and / or dietary habits.
-
Having diabetes.
-
Having a cerebrovascular disease.
-
Having a serious illness.
-
Taking products or drugs to control cholesterol levels or with antioxidant activity.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Domca Sau | Alhendín | Granada | Spain | 18620 |
Sponsors and Collaborators
- DOMCA S.A.
Investigators
- Principal Investigator: Miguel Quesada, MD, Endocrinology and Nutrition Clinic of Dr. Miguel Quesada
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- C003